Bayer to Pay $7.25 Billion in Roundup Cancer Settlement Approved by Missouri Judge
A Missouri judge has approved a $7.25 billion deal to settle the Roundup cancer lawsuits.
A Missouri judge on Friday gave final approval to a $7.25 billion settlement that could finally end one of the longest-running courtroom battles in American corporate history. The deal resolves claims from tens of thousands of Americans who say they developed cancer after using Bayer’s weedkiller Roundup, and it covers not only people who are sick today but also those who may be diagnosed with non-Hodgkin lymphoma in the years ahead.
The money will be paid out over up to 21 years through a special fund, with individual payouts ranging from $10,000 to $165,000. How much each person receives will depend on how sick they are, how old they were when diagnosed, and whether they were exposed to the weedkiller at home or at work. The settlement also sets aside $600 million for the lawyers who brought the cases.
St. Louis Circuit Judge Timothy Boyer, who approved the deal, called the payouts “fair and adequate” and described the total as among the largest mass-tort settlements in American history. Bayer chief executive Bill Anderson called the ruling “a decisive milestone” in the company’s effort to put the Roundup litigation behind it. The judge’s order can still be appealed.
About 65,000 claims are pending in courts across the United States.
The fight has shadowed Bayer ever since it bought Monsanto, the maker of Roundup, in 2018. The company already spent about $10 billion in 2020 to settle most of the cases that existed then, but an earlier attempt to resolve future claims for $1.25 billion never won court approval. Then in June, the U.S. Supreme Court ruled 7-2 in Bayer’s favor in a key case, deciding that federal pesticide law blocked state claims that the company should have added a cancer warning to Roundup’s label.
Bayer has always denied that Roundup causes cancer, pointing to decades of studies it says show the weedkiller’s key ingredient, glyphosate, is safe. Lawyers who support the deal say it guarantees that sick people will actually get paid at a time when courtroom wins are far from certain, while critics argue the payouts are too small and the agreement traps people who would rather keep fighting in court. About 200 cases in a separate federal proceeding are not covered by the deal.
With roughly 65,000 claims pending in courts across the country, the settlement — if it survives appeal — would bring a measure of closure to farmers, landscapers and homeowners who have waited years for an answer. For Bayer, it could finally lift a legal cloud that has weighed on the company for nearly a decade. For the families involved, the long wait for compensation may at last be nearing its end.
Source: Reuters
https://www.reuters.com/legal/government/missouri-judge-approves-bayers-725-billion-roundup-settlement-2026-11-20/
#USNews #BreakingNews #Bayer #Roundup #RoundupSettlement


Comments
Post a Comment